OTCMKTS:PAICU Petra Acquisition (PAICU) Stock Price, News & Analysis → 😱 This phenomenon is smashing regular market gains (From MillPub) (Ad) Free PAICU Stock Alerts $10.75 -1.97 (-15.49%) (As of 01/10/2022) Add Compare Share Share Today's Range$9.86▼$10.7550-Day Range$10.75▼$10.7552-Week Range$9.86▼$12.74Volume300 shsAverage Volume200 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Petra Acquisition alerts: Email Address Ad MillPub😱 This phenomenon is smashing regular market gainsThanks to a little-known “Pathfinder” trading phenomenon… Traders have recently unlocked one of the most powerful idea-generation sources in the history of trading. At every single market open.Click here to save your seat and join the next LIVE workshop! About Petra Acquisition Stock (OTCMKTS:PAICU)Petra Acquisition, Inc. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2019 and is based in New York, New York.Read More PAICU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PAICU Stock News HeadlinesMay 1, 2024 | americanbankingnews.comPetra Acquisition (OTCMKTS:PAICU) Shares Down 15.5% August 24, 2023 | msn.comJoPetrol attains international ISO Certifications for quality, environment, and safetyMay 1, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”February 20, 2022 | reuters.comRevelation Biosciences IncDecember 22, 2021 | finance.yahoo.comPetra Acquisition, Inc. Announces Share Redemption Backstop and Forward Purchase Agreements in Connection with Revelation Biosciences, Inc. Business CombinationDecember 16, 2021 | finance.yahoo.comPetra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Biosciences, Inc.December 16, 2021 | benzinga.comPetra Acquisition, Inc. Announces Special Meeting of Stockholders to Approve Business Combination with Revelation Biosciences, Inc.December 6, 2021 | finance.yahoo.comRevelation Biosciences Inc. Appoints Joseph A. Bellanti, M.D. to Scientific Advisory BoardMay 1, 2024 | Banyan Hill Publishing (Ad)READ THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”December 1, 2021 | finance.yahoo.comRevelation Biosciences Inc. Announces Initiation of a Phase 2b Study to Assess Efficacy of Intranasal REVTx-99 for The Prevention of H3N2 InfluenzaNovember 29, 2021 | finance.yahoo.comRevelation Biosciences Inc. Announces Creation and Appointments to Scientific Advisory BoardNovember 1, 2021 | finance.yahoo.comRevelation Biosciences Inc. Engages Partnering Advisor, MedWorld Advisors, to Optimize Value of the Company’s Diagnostic Tool, REVID™October 26, 2021 | apnews.comRevelation Biosciences Inc. Engages Destum Partners Inc. to Identify Strategic Partners for ...October 5, 2021 | apnews.comRevelation Biosciences Inc. Receives Approval to Begin a Phase 1b Clinical Study of REVTx-99 as ...October 4, 2021 | finance.yahoo.comRevelation Biosciences Inc. Receives Approval to Begin a Phase 1b Clinical Study of REVTx-99 as an Experimental Treatment for Allergic Rhinitis and Chronic Nasal CongestionSeptember 28, 2021 | finance.yahoo.comRevelation Biosciences Inc. Receives Approval to Initiate Phase 2b Viral Challenge Study of REVTx 99, an Experimental Prophylactic Treatment for the Prevention of Respiratory Viral InfectionsAugust 30, 2021 | finance.yahoo.comRespiratory Viral Infections-Focused Revelation Biosciences Turns To SPAC Deal For NASDAQ DebutAugust 30, 2021 | businesswire.comRevelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded ...August 30, 2021 | finance.yahoo.comRevelation Biosciences, Inc., a Life Sciences Company Developing Therapeutics and Diagnostics for Respiratory Viral Infections, Including COVID-19, to Become Publicly Traded Through a Merger with Petra Acquisition, Inc.See More Headlines Receive PAICU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Petra Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinance Industry Shell Companies Sub-IndustryN/A Current SymbolOTCMKTS:PAICU CUSIPN/A CIK1810560 WebN/A PhoneN/AFaxN/AEmployees2Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Andreas A. Typaldos (Age 74)Chairman, CEO & Sec. Mr. Sean H. Fitzpatrick (Age 55)CFO & Director Key Competitors10X Capital Venture AcquisitionOTCMKTS:VCVCU890 5th Avenue PartnersOTCMKTS:ENFAUACE Convergence AcquisitionOTCMKTS:ACEVUACON S2 AcquisitionOTCMKTS:STWOUAlpha Capital AcquisitionOTCMKTS:ASPCUView All Competitors PAICU Stock Analysis - Frequently Asked Questions How have PAICU shares performed in 2024? Petra Acquisition's stock was trading at $10.75 at the beginning of 2024. Since then, PAICU stock has increased by 0.0% and is now trading at $10.75. View the best growth stocks for 2024 here. How do I buy shares of Petra Acquisition? Shares of PAICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PAICU) was last updated on 5/1/2024 by MarketBeat.com Staff From Our PartnersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersElon’s New Device is About to Shock the WorldInvestorPlace😱 This phenomenon is smashing regular market gainsMillPubYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Petra Acquisition, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
